Recursion Pharmaceuticals Inc Cl A (RXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -121,546 | -74,118 | -30,717 | -87,006 | -61,240 |
| Depreciation Amortization | 6,169 | 3,733 | 1,402 | 3,943 | 2,818 |
| Accounts receivable | -6,746 | -2,362 | -2,830 | N/A | -30,048 |
| Accounts payable and accrued liabilities | 5,252 | 2,122 | 2,051 | -185 | 37 |
| Other Working Capital | 3,653 | -3,637 | -4,630 | 30,834 | -720 |
| Other Operating Activity | 15,762 | 9,854 | 3,969 | 7,015 | 35,181 |
| Operating Cash Flow | $-97,456 | $-64,408 | $-30,755 | $-45,399 | $-53,972 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -184,167 | N/A | N/A | N/A | N/A |
| PPE Investments | -35,334 | -25,628 | -19,416 | -5,831 | -2,144 |
| Net Acquisitions | N/A | N/A | N/A | -2,600 | -2,600 |
| Purchase Of Investment | N/A | N/A | N/A | 595 | 595 |
| Purchase Sale Intangibles | N/A | N/A | N/A | -904 | N/A |
| Other Investing Activity | 0 | 0 | 0 | -904 | 0 |
| Investing Cash Flow | $-219,501 | $-25,628 | $-19,416 | $-8,740 | $-4,149 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 6,400 | 6,400 |
| Debt Repayment | -12,777 | -40 | -20 | -77 | -57 |
| Common Stock Issued | 462,901 | 462,901 | N/A | N/A | N/A |
| Other Financing Activity | 4,620 | 2,978 | 2,154 | 239,812 | 229,757 |
| Financing Cash Flow | $454,744 | $465,839 | $2,134 | $246,135 | $236,100 |
| Beginning Cash Position | 267,167 | 267,167 | 267,167 | 75,171 | 75,171 |
| End Cash Position | 404,954 | 642,970 | 219,130 | 267,167 | 253,150 |
| Net Cash Flow | $137,787 | $375,803 | $-48,037 | $191,996 | $177,979 |
| Free Cash Flow | |||||
| Operating Cash Flow | -97,456 | -64,408 | -30,755 | -45,399 | -53,972 |
| Capital Expenditure | -35,334 | -25,628 | -19,416 | -5,831 | -2,144 |
| Free Cash Flow | -132,790 | -90,036 | -50,171 | -51,230 | -56,116 |